<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Dozee Secures CE Mark, Cementing Its Global Presence in Remote Patient Monitoring (RPM) and Early Warning Systems (EWS) Market</title>
    <link>https://www.taxtmi.com/news?id=48240</link>
    <description>The CE Mark under the European Union Medical Device Regulation authorizes Dozee&#039;s contactless vital signs monitoring system-classified as Class IIb-for market access across the EEA after Notified Body assessment of its quality management system, technical documentation, and clinical validation. The device&#039;s contactless sensors and algorithms monitor key vital signs to detect patient deterioration, and the CE Mark, alongside prior US FDA 510(k) clearance, evidences conformity with international regulatory safety and performance requirements to support broader clinical deployment.</description>
    <language>en-us</language>
    <pubDate>Wed, 02 Jul 2025 15:01:03 +0530</pubDate>
    <lastBuildDate>Wed, 02 Jul 2025 15:01:03 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=833227" rel="self" type="application/rss+xml"/>
    <item>
      <title>Dozee Secures CE Mark, Cementing Its Global Presence in Remote Patient Monitoring (RPM) and Early Warning Systems (EWS) Market</title>
      <link>https://www.taxtmi.com/news?id=48240</link>
      <description>The CE Mark under the European Union Medical Device Regulation authorizes Dozee&#039;s contactless vital signs monitoring system-classified as Class IIb-for market access across the EEA after Notified Body assessment of its quality management system, technical documentation, and clinical validation. The device&#039;s contactless sensors and algorithms monitor key vital signs to detect patient deterioration, and the CE Mark, alongside prior US FDA 510(k) clearance, evidences conformity with international regulatory safety and performance requirements to support broader clinical deployment.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Wed, 02 Jul 2025 15:01:03 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=48240</guid>
    </item>
  </channel>
</rss>